NEW YORK (Reuters Health) – Neoadjuvant treatment with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor, can help downstage bladder cancer to organ-confined disease, thereby increasing the…
NEW YORK (Reuters Health) – Coronary angiography is a recommended screening test for many patients undergoing kidney transplantation and now new research shows that it can be performed…
NEW YORK (Reuters Health) – Deferring percutaneous coronary intervention (PCI) and treating high-risk heart disease patients with optimal medical therapy alone does not increase the risk of death,…
NEW YORK (Reuters Health) – Treatment with the third generation bisphosphonate zoledronic acid (Zometa) may improve survival in lung cancer patients with bone metastases, Greek researchers report. Between…
NEW YORK (Reuters Health) – Elevated pre-operative blood levels of brain natriuretic peptide (BNP) or N-terminal-proBNP identify patients who are at increased risk for cardiovascular events within 30…
NEW YORK (Reuters Health) – While minimally invasive radical prostatectomy (MIRP) offers certain advantages over open retropubic radical prostatectomy (RRP), such as a shorter hospital stay, it also…
NEW YORK (Reuters Health) – Tamoxifen therapy has been linked to an increased risk of deep venous thrombosis (DVT) and pulmonary embolism (PE) and now new research suggests…
NEW YORK (Reuters Health) – When adverse events were compared between patients who received single versus multiple coronary stents, there were few complications overall and only a trend…
NEW YORK (Reuters Health) – Stress testing can be safely done in asymptomatic patients with severe aortic stenosis and is useful in predicting adverse cardiac events, including sudden…
NEW YORK (Reuters Health) – In patients with mild renal insufficiency, a single IV bolus of sodium bicarbonate can help prevent contrast-induced nephropathy (CIN) during percutaneous coronary intervention…
NEW YORK (Reuters Health) – The benefit of adding inhaled corticosteroids to long-acting beta-2 agonists for treating chronic obstructive pulmonary disease (COPD) is limited, and furthermore, it’s accompanied…
NEW YORK (Reuters Health) – In patients receiving first-line treatment for metastatic colon cancer, planned complete discontinuation of chemotherapy had a negative impact on duration of disease control…
